Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot trainer boosts stroke rehab – but does side of weakness matter?

NCT ID NCT07280884

Symptom relief Sponsor: University School of Physical Education, Krakow, Poland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a robotic device called Luna EMG, which uses muscle signals to assist movement, can improve walking and balance in people recovering from a stroke. 62 older adults with leg weakness after a stroke were randomly assigned to get either robotic training plus standard physiotherapy or standard physiotherapy alone. The researchers also looked at whether the side of the body affected by the stroke changed the results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Luna EMG robotic training device
What this could lead to
If successful, this could point toward a more effective rehab approach for stroke survivors, potentially improving walking and balance.
What could go wrong
This is a small, early-stage study with only 62 participants. Results may not apply to all stroke patients, and the device may not offer clear benefits over standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

62 people

The number who actually took part.

Started

May 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 86 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of primary ischemic stroke * Time from stroke: 4 to 15 weeks * Age between 65 and 86 years * Limited or impaired lower limb function * Ability to walk 10 meters independently or with orthopedic assistance * Muscle strength of at least -3 on the modified Medical Research Council (MRC) scale * Cognitive function sufficient to understand instructions and participate in the study * Stable clinical status * Provided written informed consent Exclusion Criteria: * Hemorrhagic stroke or stroke in the posterior cerebral circulation * Lower limb spasticity greater than 1+ on the modified Ashworth Scale (MAS) * Functional limitations preventing the completion of selected tests * Recent orthopedic injuries affecting balance * Prior lower limb surgery * Sensory aphasia * Coexisting neurological disorders (e.g., Parkinson's disease, Huntington's disease) * Lack of patient cooperation or refusal to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia ischemic stroke Mobility Limitation Paresis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gait disorders Hemiparesis Ischemic stroke

Contacts and locations

Locations

  • Non-Public Health Care Center "Rehstab" (NZOZ "RehStab")

    Limanowa, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.